Role of ovary and adrenal glands in hyperandrogenemia in patients with polycystic ovary syndrome

Experimental and Clinical Endocrinology and Diabetes

Volumn 113, Issue 2, 2005, Pages 115-121

  Kamel, N ^a   Tonyukuk, V ^a   Emral, R ^a   Corapcioglu D ^a   Bastemir M ^a   Gullu S ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Adrenal gland; Buserelin stimulation test; Ovary; Polycystic ovary syndrome

Indexed keywords

BUSERELIN; CORTICOTROPIN; HYDROCORTISONE; PRASTERONE SULFATE; STEROID 17ALPHA MONOOXYGENASE;

ADRENAL GLAND; ARTICLE; CONTROLLED STUDY; FEMALE; HIRSUTISM; HUMAN; HYPERANDROGENISM; MAJOR CLINICAL STUDY; OVARY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROVOCATION TEST;

ADRENAL GLANDS; ADULT; DEHYDROEPIANDROSTERONE SULFATE; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; HYPERANDROGENISM; LUTEINIZING HORMONE; OVARY; POLYCYSTIC OVARY SYNDROME;

EID: 15244343328     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-830540     Document Type: Article

References (33)

1. Azziz R, Boots LR, Parker CR Jr, Bradley E Jr, Zacur HA. 11 beta-hydroxylase deficiency in hyperandrogenism. Fertil Steril 1991; 55: 733-741
2. Azziz R, Bradley EL Jr, Potter HD, Boots LR. Adrenal androgen excess in women: lack of a role for 17-hydroxylase and 17,20 lyase dysregulation. J Clin Endocrinol Metab 1995; 80: 400-405
3. Azziz R, Rafi A, Smith BR, Bradley EL Jr, Zacur HA. On the origin of the elevated 17-hydroxyprogesterone levels after adrenal stimulation in hyperandrogenism. J Clin Endocrinol Metab 1990; 70: 431-436
4. Azziz R, Rittmaster RS, Fox LM, Bradley EL Jr, Potter HD, Boots LR. Role of the ovary in the adrenal androgen excess of hyperandrogenic women. Fertil Steril 1998; 69: 851-859
5. Barnes RB, Rosenfield RL, Burstein S, Ehrmann DA. Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome. N Engl J Med 1989; 320: 559-565
6. Chetkowski RJ, Chang RJ, DeFazio J, Meldrum DR, Judd HL. Origin of serum progestins in polycystic ovarian disease. Obstet Gynecol 1984; 64: 27-31
7. Ehrmann DA, Barnes RB, Rosenfield RL. Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocr Rev 1995; 16: 322-353
8. Ehrmann DA, Rosenfield RL, Barnes RB, Brigell DF, Sheikh Z. Detection of functional ovarian hyperandrogenism in women with androgen excess. N Engl J Med 1992; 327: 157-162
9. Erel CT, Senturk LM, Oral E, Colgar U, Ertungealp E. Adrenal androgenic response to 2-hour ACTH stimulation test in women with PCOS. Gynecol Endocrinol 1998; 12: 223-229
10. Hatch R, Rosenfield RL, Kim MH, Tredway D. Hirsutism: implications, etiology, and management. Am J Obstet Gynecol 1981; 140: 815-830
11. Horvath E, Varga B, Stark E. Stimulation of progesterone production by adrenocorticotropic hormone and prostaglandin E2 in rat luteal cells. Biol Reprod 1986; 35: 44-48
12. Ibanez L, Potau N, Zampolli M, Prat N, Gussinye M, Saenger P, Vicens-Calvet E, Carrascosa A. Source localization of androgen excess in adolescent girls. J Clin Endocrinol Metab 1994; 79: 1778-1784
13. Kandarakis ED, Dunaif A. New perspectives in polycystic ovary syndrome. Trends Endocrinol Metab 1996; 7: 267-271
14. Keleştimur F, Şahin Y. Alternate pathway 17,20-lyase enzyme activity in the adrenals is enhanced in patients with polycystic ovary syndrome. Fertil Steril 1999; 71: 1075-1078
15. Keleştimur F, Şahin Y, Ayata D, Tutuş A. The prevalence of non-classic adrenal hyperplasia due to 11β-hydroxylase deficiency among hirsute women in a Turkish population. Clin Endocrinol (Oxford) 1996; 45: 381-384
16. Lewis V: Polycystic ovary syndrome - A diagnostic challenge. Obstet Gynecol Clin North Am 2001; 28: 1-20
17. Licht P, Wildt L. Luteal and extraluteal receptors for hCG and LH. Zentralbl Gynakol 1998; 120: 98-105
18. Lin CJ, Jorge AA, Latronico AC, Marui S, Fragoso MC, Martin RM, Carvalho FM, Arnhold IJ, Mendonca BB. Origin of an ovarian steroid cell tumor causing isosexual pseudoprecocious puberty demonstrated by the expression of adrenal steroidogenic enzymes and adrenocorticotropin receptor. J Clin Endocrinol Metab 2000; 85: 1211-1214
19. Martikainen H, Salmela P, Nuojua-Huttunen S, Perala J, Leinonen S, Knip M, Ruokonen A. Adrenal steroidogenesis is related to insulin in hyperandrogenic women. Fertil Steril 1996; 66: 564-570
20. Meikle AW, Worley RJ, West CD. Adrenal corticoid hyperresponsiveness in hirsute women. Fertil Steril 1984; 41: 575-579
21. Miller WL. Molecular biology of steroid hormone synthesis. Endocr Rev 1988; 9: 295-318
22. Moltz L, Schwartz U. Gonadal and adrenal androgen secretion in hirsute females. J Clin Endocrinol Metab 1986; 15: 229-245
23. Pabon JE, Li X, Lei ZM, Sanfilippo JS, Yussman MA, Rao CV. Novel presence of luteinizing hormone/chorionic gonadotropin receptors in human adrenal glands. Clin Endocrinol Metab. 1996; 81: 2397-2400
24. Rosenfield RL, Barnes RB, Cara JF, Lucky AW. Dysregulation of cytochrome P450c17-α as the cause of polycystic ovarian syndrome. Fertil Steril 1990; 53: 785-791
25. Rosenfield RL, Barnes RB, Ehrmann DA. Studies of the nature of 17 hydroxyprogesterone hyperresponsiveness to gonadotropin-releasing hormone agonist challenge in functional ovarian hyperandrogenism. J Clin Endocrinol Metab 1994; 79: 1686-1692
26. Şahin Y, Ayata D, Keleştimur F. Lack of relationship between 17-hydroxyprogesterone response to buserelin testing and hyperinsulinemia in polycystic ovary syndrome. Eur J Endocrinol 1997; 136: 410-415
27. Şahin Y, Keleştimur F. 17-hydroxyprogesterone response to buserelin testing in the polycystic ovary syndrome. Clin Endocrinol (Oxf) 1993; 39: 151-155
28. Şahin Y, Keleştimur F. 17-hydroxyprogesterone responses to gonadotrophin-releasing hormone agonist buserelin and adrenocorticotrophin in polycystic ovary syndrome: investigation of adrenal and ovarian cytochrome P450c17-α dysregulation. Hum Reprod 1997 a; 12: 910-913
29. Şahin Y, Keleştimur F. The frequency of late-onset 21-hydroxylase and 11 beta-hydroxylase deficiency in women with polycystic ovary syndrome. Eur J Endocrinol 1997 b; 137: 670-674
30. Takayama K, Fukaya T, Sasano H, Funayama Y, Suzuki T, Takaya R, Wada Y, Yajima A. Immunohistochemical study of steroidogenesis and cell proliferation in polycystic ovarian syndrome. Hum Reprod 1996; 11: 1387-1392
31. Tsilchorozidou T, Honour JW, Conway GS. Altered cortisol metabolism in polycystic ovary syndrome: insulin enhances 5 alpha-reduction but not the elevated adrenal steroid production rates. J Clin Endocrinol Metab. 2003; 88: 5907-5913
32. Turner EI, Watson MJ, Perry LA, White MC. Investigation of adrenal function in women with oligomenorrhoea and hirsutism (clinical PCOS) from the north-east of England using an adrenal stimulation test. Clin Endocrinol (Oxford) 1992; 36: 389-397
33. White D, Leigh A, Wilson C, Donaldson A, Franks S. Gonadotrophin and gonadal steroid response to a single dose of a long-acting agonist of gonadotrophin-releasing hormone in ovulatory and anovulatory women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 1995; 42: 475-481